Company Filing History:
Years Active: 2009
Title: Jens Ergüden: Innovator in Medicinal Chemistry
Introduction
Jens Ergüden is a notable inventor based in Wülfrath, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his work on isophthalic acid derivatives. His innovative approach has implications for the treatment of various diseases, including cardiovascular disorders.
Latest Patents
Ergüden holds a patent for isophthalic acid derivatives. This invention relates to the preparation of these derivatives and their use in producing medicaments aimed at treating and preventing diseases in both humans and animals. The focus on cardiovascular disorders highlights the potential impact of his work on public health.
Career Highlights
Throughout his career, Jens Ergüden has worked with prominent companies in the pharmaceutical industry. He has been associated with Bayer Healthcare and Bayer Schering Pharma, where he has contributed to various projects and advancements in medicinal chemistry.
Collaborations
Ergüden has collaborated with notable professionals in his field, including Michael Härter and Frank Wunder. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in medicine.
Conclusion
Jens Ergüden's work exemplifies the intersection of innovation and healthcare. His contributions to the development of isophthalic acid derivatives demonstrate the importance of research in addressing critical health issues. His career reflects a commitment to advancing medicinal chemistry for the benefit of society.